Shares of HOOKIPA Pharma Inc. (NASDAQ:HOOK – Get Free Report) fell 3.1% during mid-day trading on Monday . The stock traded as low as $0.8350 and last traded at $0.8631. 556,256 shares traded hands during mid-day trading, an increase of 485% from the average session volume of 95,126 shares. The stock had previously closed at $0.8910.
HOOKIPA Pharma Stock Performance
The company has a 50 day moving average of $0.89 and a 200-day moving average of $1.05. The stock has a market cap of $10.55 million, a price-to-earnings ratio of -0.15 and a beta of 0.91.
HOOKIPA Pharma Company Profile
HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.
Further Reading
- Five stocks we like better than HOOKIPA Pharma
- Best Aerospace Stocks Investing
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- Energy and Oil Stocks Explained
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for HOOKIPA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HOOKIPA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
